Literature DB >> 6412669

Intravenous treatment of hypokalemic periodic paralysis.

R C Griggs, J Resnick, W K Engel.   

Abstract

Acute attacks of weakness in patients with hypokalemic periodic paralysis can usually be treated with oral potassium preparations. Occasional patients, however, require intravenous (IV) potassium administration. We studied a patient with hypokalemic periodic paralysis to determine the effect of using 5% glucose as a diluent for potassium administration during acute attacks of weakness. Administration of IV potassium chloride in 5% glucose (50 mEq/L) was associated with a worsening of strength and no rise in potassium level. Intravenous potassium in 5% mannitol was associated with a rise in potassium and improvement in strength. This study confirms the hazard of using glucose-containing solutions for correction of hypokalemia.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6412669     DOI: 10.1001/archneur.1983.04050080039005

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  15 in total

Review 1.  Hypokalaemic paralysis.

Authors:  S K Ahlawat; A Sachdev
Journal:  Postgrad Med J       Date:  1999-04       Impact factor: 2.401

Review 2.  Neurological channelopathies.

Authors:  T D Graves; M G Hanna
Journal:  Postgrad Med J       Date:  2005-01       Impact factor: 2.401

3.  Thyrotoxic hypokalemic periodic paralysis in a Turkish male with graves' disease: a rare case report and review of the literature.

Authors:  Cihangir Erem
Journal:  Endocrine       Date:  2005-06       Impact factor: 3.633

4.  Anaesthetic management of a patient with hypokalemic periodic paralysis- a case report.

Authors:  S Chitra; Grace Korula
Journal:  Indian J Anaesth       Date:  2009-04

Review 5.  Thyrotoxic periodic paralysis: clinical and molecular aspects.

Authors:  Henrik Falhammar; Marja Thorén; Jan Calissendorff
Journal:  Endocrine       Date:  2012-08-24       Impact factor: 3.633

Review 6.  Clinical evaluation of membrane excitability in muscle channel disorders: potential applications in clinical trials.

Authors:  James C Cleland; Eric L Logigian
Journal:  Neurotherapeutics       Date:  2007-04       Impact factor: 7.620

Review 7.  Skeletal Muscle Channelopathies.

Authors:  Lauren Phillips; Jaya R Trivedi
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

8.  A rare case of thyrotoxic periodic paralysis precipitated by hydrocortisone.

Authors:  Subrata Chakrabarti
Journal:  J Nat Sci Biol Med       Date:  2015 Jan-Jun

9.  Hypokalemic periodic paralysis.

Authors:  Haider Abbas; Nikhil Kothari; Jaishri Bogra
Journal:  Natl J Maxillofac Surg       Date:  2012-07

10.  Practical aspects in the management of hypokalemic periodic paralysis.

Authors:  Jacob O Levitt
Journal:  J Transl Med       Date:  2008-04-21       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.